Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions

2011 ◽  
Vol 105 (02) ◽  
pp. 313-320 ◽  
Author(s):  
Masaaki Hamada ◽  
Hideto Matsui ◽  
Tomohiro Mizuno ◽  
Yasuaki Shida ◽  
Masaaki Doi ◽  
...  

SummaryIn addition to lowering cholesterol, the 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitors (statins) have a range of pleiotropic effects that help reduce the risk of adverse cardiovascular events. We sought to understand the molecular mechanisms by which statins could exert anti-platelet actions under physiologic whole blood flow conditions. Using an in vitroperfusion chamber system, we examined the anti-platelet effects of pravastatin under whole blood flow conditions with high or low shear rates. We determined that pravastatin significantly suppressed platelet activation-dependent procoagulant activity, decreasing P-selectin membrane expression, tissue factor accumulation, and thrombin binding within platelet thrombi generated on a von Willebrand factor-surface under high shear rate conditions. These effects resulted in reductions of intra-thrombus fibrin deposition. These antithrombotic properties of pravastatin, which were comparable to those of atorvastatin, could be abrogated by mevalonate. Our experimental approach revealed a novel mechanism mediating the anti-platelet action of statins. Shear rate-dependent antithrombotic activity may explain the favourable effect of pravastatin on the reduction in cardiovascular events that typically occur in vivounder whole blood flow conditions with high shear rates.

Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 2199-2199
Author(s):  
Masaaki Doi ◽  
Mitsuhiko Sugimoto ◽  
Hideto Matsui ◽  
Tomoko Matsumoto ◽  
Midori Shima

Abstract Abstract 2199 Coagulation factor VIII (FVIII), lacking in hemophilic blood, plays an essential role in mechanisms of fibrin plug formation to arrest bleeding at sites of injured vessel walls. Physiologic activity of FVIII circulating in bloodstream (soluble FVIII; S-FVIII) could be extensively evaluated so far by classic plasma coagulation assays such as activated partial thromboplastin time. However, the in vivo functional relevance of FVIII bound to von Willebrand factor (VWF) which is immobilized in subendothelium (immobilized FVIII; I-FVIII) is more complex and remains to be addressed. Using an in vitro perfusion chamber system, we have therefore evaluated the function of I-FVIII in the process of mural thrombus generation under whole blood flow conditions. FVIII-free VWF was purified in the presence of 0.35 M CaCl2 from cryoprecipitate, and coated on a glass plate. Various concentrations (0 as a control, 0.1, 0.3, 1, or 3 U/ml) of recombinant FVIII (Kogenate FS provided by Bayer Pharmaceutical Co.) were reacted with the FVIII-free VWF-coated glass plate. After non-adherent proteins were washed out, the amount of FVIII immobilized to a glass surface via VWF (I-FVIII) was measured by ELISA-based assay using a peroxidase-conjugated anti-FVIII polyclonal antibody. Whole blood was then perfused over a glass plate described above in a parallel plate flow chamber with various shear rates, and the thrombus generation process on a glass surface was observed in real time by confocal laser scanning microscopy. The development of intra-thrombus fibrin deposition was assessed by immune-staining of thrombi with a fluorescence-labeled anti-fibrin specific monoclonal antibody (NYB-T2G1; Accurate Chem.), reflecting solid-phase blood coagulation reaction during mural thrombogenesis. In perfusion of control blood with a high shear rate (1500 s-1), the intra-thrombus fibrin deposition was found to increase as a function of I-FVIII, resulting in the 2.5-fold greater fibrin deposition at the plateau as compared to control thrombi generated in the absence of I-FVIII. This I-FVIII effect on intra-thrombus fibrin deposition was also confirmed in perfusion of synthetic hemophilic blood (S-FVIII activity < 1%) which was prepared by the incubation of control blood with an anti-FVIII human IgG (final inhibitor titer in synthetic blood; 5, 10, or 20 Bethesda U/ml). Indeed, I-FVIII normalized in a dose-dependent manner the reduced fibrin deposition (20-35% of normal control) within synthetic hemophilic thrombi generated in the absence of S-FVIII under a high shear rate condition. The improvement of impaired fibrin deposition by I-FVIII was unvarying regardless of the anti-FVIII inhibitor titer in synthetic hemophilic blood. In contrast, the direct addition of recombinant FVIII into synthetic hemophilic blood was poorly effective in this regard, due to the immediate neutralization of S-FVIII by an inhibitor involved in synthetic blood. Thus, these results clearly indicate that I-FVIII, independent of S-FVIII, does play a considerable role on the intra-thrombus fibrin-network formation in the process of mural thrombus generation under whole blood flow conditions with high shear rate, most relevant physiologically for the in vivo hemostasis and thrombosis. Our results might imply a possibility of novel strategic design targeting I-FVIII against hemophilic patients with a high titer anti-FVIII inhibitor. Disclosures: No relevant conflicts of interest to declare.


2021 ◽  
Vol 15 (3) ◽  
pp. 181-190
Author(s):  
Elif H Ozcan Cetin ◽  
Mehmet S Cetin ◽  
Mustafa B Ozbay ◽  
Hasan C Könte ◽  
Nezaket M Yaman ◽  
...  

Aim: We aimed to assess the association of whole blood with thromboembolic milieu in significant mitral stenosis patients. Methodology & results: We included 122 patients and classified patients into two groups as having thrombogenic milieu, thrombogenic milieu (+), otherwise patients without thrombogenic milieu, thrombogenic milieu (-). Whole blood viscosity (WBV) in both shear rates were higher in thrombogenic milieu (+) group comparing with thrombogenic milieu (-). WBV at high shear rate and WBV at low shear rate parameters were moderately correlated with grade of spontaneous echo contrast. Adjusted with other parameters, WBV parameters at both shear rates were associated with presence of thrombogenic milieu. Discussion & conclusion: We found that extrapolated WBV at both shear rates was significantly associated with the thrombogenic milieu in mitral stenosis. This easily available parameter may provide additional perspective about thrombogenic diathesis.


Blood ◽  
1994 ◽  
Vol 84 (7) ◽  
pp. 2206-2213 ◽  
Author(s):  
A Diquelou ◽  
S Lemozy ◽  
D Dupouy ◽  
B Boneu ◽  
K Sakariassen ◽  
...  

We have investigated the influence of blood flow on thrombin generation, fibrin formation, and fibrin deposition on procoagulant and nonprocoagulant surfaces. Nonanticoagulated human blood was drawn for 5 minutes directly from an antecubital vein over stimulated endothelial cells expressing tissue factor and over human type III collagen fibrils, positioned in parallel-plate perfusion chambers. The shear rates at these surfaces were 50, 650, and 2,600 s-1. Deposition of platelets and fibrin was measured by morphometry. Thrombin and fibrin formation was determined by measuring prothrombin fragments 1 + 2 (F 1 + 2), thrombin-antithrombin III complexes, (T-AT) and fibrinopeptide A (FPA) in blood effluent from the perfusion chamber at the end of the 5- minute perfusion period. On procoagulant endothelial cells, the thrombi were primarily composed of fibrin. The fibrin deposition (81%, 21%, and 2% at 50, 650, and 2,600 s-1, respectively) and plasma levels of F 1 + 2, T-AT and FPA were shear rate dependent and highest at 50 s-1. There was a positive correlation between F 1 + 2 and T-AT and the fibrin deposition (P < .01). In contrast, the collagen surface triggered primarily thrombi that were composed of platelets. The platelet thrombi and plasma levels of F 1 + 2 and T-AT were also dependent on the shear rate, but highest at 650 and 2,600 s-1. F 1 + 2 and T-AT reached the same level as observed with procoagulant endothelial cells at the higher shear rates. There was a positive correlation between F 1 + 2 and T-AT and the platelet thrombus formation (P < .05), confirming the predominant role of platelets in thrombin generation. Thus, thrombin formation is strongly influenced by the blood flow, and this effect depends on the composition of the thrombogenic surface.


Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 5191-5191
Author(s):  
Khon C. Huynh ◽  
Volker R. Stoldt ◽  
Marianna Gyenes ◽  
Rüdiger E. Scharf

Abstract Abstract 5191 Introduction: To fulfill their role in hemostasis, circulating platelets need to irreversibly adhere to the site of vascular injury and to resist to shear stress generated by the flowing blood. We previously reported that there is a relationship between the conformation of fibronectin (Fn) and its role in platelet adhesion and aggregation (Huynh, K. C. et al., ASH Annual Meeting Abstract, 2011. 118(21): p. 2209). In the present study, we examined the effect of shear stress on the assembly of Fn by adherent platelets. Moreover, we studied the role of β3 integrins (αIIbβ3 and αvβ3) in Fn assembly under flow conditions. Methods: Alexa fluor 488-conjugated fibronetin (Fn488) was added to suspensions of washed platelets (108/ml) in HEPES Tyrode buffer. CaCl2 (2 mM) and ADP (10 μM) were added immediately prior to the experiments. The samples (150 μl) were subsequently applied onto plates precoated with 50 μg/ml Fn. A DiaMed Impact-R device was used to generate shear rates of 500 s−1 or 5000 s−1 for 2 min or 10 min. Nonadherent platelets were removed by washing with PBS buffer followed by addition of 150 μl of 2 % DOC lysis buffer. Lysates were collected and total protein concentrations were determined by Bradford assay. The DOC-insoluble pellets containing Fn fibrils were isolated by centrifugation at 13, 500 rpm for 20 min. Pellets were then solubilized with 100 μl of 1 % SDS buffer. Equal amounts of samples based on total protein concentrations were loaded onto wells of 96-well microplates. Fluorescence signals from Fn488 of samples were recorded by a Fluoroskan microplate reader. In some experiments, abciximab (anti-β3, 10 μg/ml) or LM609 (anti-αvβ3, 5 μg/ml) antibody, were added to platelet mixtures before loading onto Fn precoated plates. All data were collected from at least three different experiments and analyzed using GraphPad Quickcals. To test for statistical differences, student's t-test was used. Results: Fn assembly by adherent platelets was strongly affected by the applied shear rate but not by the exposure time to shear. At a shear rate of 500 s−1, there were no insoluble Fn fibrils detectable in samples with adherent platelets after 2 or 10 min. When shear rates increased from 500 s−1 to 5000 s−1, the amount of insoluble Fn detectable on platelets after 2 and 10 min increased significantly (p < 0. 05) suggesting that adherent platelets exposed to high shear rates assemble more Fn fibrils on their surface. However, prolongation of exposure time to shear from 2 to 10 min did not result in significantly more Fn assembled by adherent platelets. By contrast, there were no insoluble fibrils that could be detected with adherent platelets under static conditions for 2 and 10 min. After 2 min at a shear rate of 5000 s−1, platelets blocked with abciximab showed a significant decrease in the amounts of insoluble Fn fibrils in comparison with control experiments (no antibody) (p = 0. 02). Similar inhibitory effects could be seen with platelets treated with LM609. In parallel experiments in which 10 min at 5000 s−1 were applied, both abciximab and LM609 had an inhibitory effect on Fn fibrillogenesis with a stronger effect by abciximab. Taken together, these data show that αvβ3 even at the low expression on platelets plays a major role in initiating the fibrillogenesis of Fn under high shear rate conditions, whereas αIIbβ3 contributes to the progression of Fn fibrils formation subsequently. Conclusion: Our observations document that the assembly of Fn on the surface of adherent platelets is strongly affected by shear rate conditions. In addition, our data imply that, despite its lower expression on platelet surface, αvβ3 provides a significant contribution in initiating the Fn assembly under high flow conditions, as compared with αIIbβ3. By contrast, αIIbβ3 with its abundant amount on the platelet surface probably exerts its effect in the later phase of Fn fibrillogenesis. The present findings support the contention that not a single integrin or Fn binding domain, but multiple interaction steps including different molecules and Fn domains may be involved in assembling Fn. Disclosures: No relevant conflicts of interest to declare.


Blood ◽  
2008 ◽  
Vol 111 (3) ◽  
pp. 1295-1298 ◽  
Author(s):  
Yasuaki Shida ◽  
Kenji Nishio ◽  
Mitsuhiko Sugimoto ◽  
Tomohiro Mizuno ◽  
Masaaki Hamada ◽  
...  

Abstract The metalloprotease ADAMTS13 is assumed to regulate the functional levels of von Willebrand factor (VWF) appropriate for normal hemostasis in vivo by reducing VWF multimer size, which directly represents the thrombogenic activity of this factor. Using an in vitro perfusion chamber system, we studied the mechanisms of ADAMTS13 action during platelet thrombus formation on a collagen surface under whole blood flow conditions. Inhibition studies with a function-blocking anti-ADAMTS13 antibody, combined with immunostaining of thrombi with an anti-VWF monoclonal antibody that specifically reflects the VWF-cleaving activity of ADAMTS13, provided visual evidence for a shear rate–dependent action of ADAMTS13 that limits thrombus growth directly at the site of the ongoing thrombus generation process. Our results identify an exquisitely specific regulatory mechanism that prevents arterial occlusion under high shear rate conditions during mural thrombogenesis.


Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 3580-3580 ◽  
Author(s):  
Vanessa Perez ◽  
Max E Johansen ◽  
Wenche Jy ◽  
Larry Horstman ◽  
Yeon S Ahn

Abstract Background Red cell microparticles (RMP) have come to recent attention as putative mediators of hemostasis. We reported that RMP improve hemostatic defect of blood samples of thrombocytopenia and thrombocytopathy and augment platelet function. To investigate possible mechanisms of this activity, we measured the effect of RMP on shear-dependent platelet adhesion and aggregation in whole blood. Methods RMP were produced by high-pressure extrusion of washed, packed RBC. The RMP produced in this way are similar to natural circulating RMP in phenotype and most functional assays. Blood was collected in citrate Vacutainers from normal healthy staff volunteers, and first 3 mL discarded to minimize artifact of platelet activation due to tissue factor. It was tested within 2 hours of drawing. Variable shearing rates were applied by a cone-and-plate device, the DiaMed Impact-R, which yields photomicrographs of objects adhering to the plate, and data including percent surface coverage (SC), number objects adhering (OBJ) per mm2, and mean aggregate size (AS) in μm2. Initially, 4μL of either RMP (1.0 x 108/μL) or saline were mixed with 126μL of whole blood obtained as above, and incubated in a microcentrifuge tube for 60s. The mixtures were pipetted to a well of the device and run at a selected shear rate (range 900s-1 to 2700s-1) for 2 minutes. Blood was then carefully drawn off and the wells were washed gently with deionized water. Wells were stained with May-Grünwald stain for 60s, and excess removed. When dry, micrographs of the well surfaces were taken. The most promising shear rates (1125 s-1, 1575s-1, 1800s-1, 2025s-1) were retested with higher numbers of RMP in the 130μL volume. Results Addition of RMP vs. saline (control) induced increased AS over a range of shear rates. For example, 4μL RMP (1x108/μL) running at 2250s-1 increased AS by 34.8%, from 59.2 ±25.1μm2 to 79.8 ±24.7μm2 (n=15, p=0.01). To investigate effect of RMP concentration at fixed shear rate of 1575s-1, we found that 8μL RMP induced increase of 12.0 μm2, 12μL RMP by 24.8 μm2, 16μL by 26.7 μm2, and 20μL by 26.3 μm2; p<0.05 and n=4 replicates for all. As seen by the trend, this effect on AS reached a plateau at 20 μL RMP. With fixed volume of RMP added and varying shear rate, we found the largest RMP-induced increase in AS occurred at 1125s-1 shear rate: 16μL of RMP increased aggregate size to 172% of control (from 41.3 ±10.2μm2 to 71.0 ±2.6μm2; n=3, p=0.02). With 1/4 as much RMP (4 μL), the peak effect occurred at 1125s-1. We did not observe any significant differences in SC at any shear rate or RMP volume. OBJ was generally lower as AS increased, but this did not reach significance. Conclusion/Discussion RMP increased the size of platelet aggregates under shear, indicating enhanced platelet adhesion by RMP. This effect varied with shear rate: larger amounts of RMP had maximum effect at lower shear rates; smaller amounts of RMP required higher shear to exert maximum effect. These effects are seen at physiologically relevant shear rates (200 - 2000s-1 or higher in pathology such as hypertension or valve defects). Due to the absence of endothelia from this model, high shear was required to induce maximum adhesion. Previous study has indicated the important role of GPIIb/IIIa in platelet adhesion and aggregate size under high shear [Varon, et al; Am Heart J, 1998]. We postulate that RMP may be acting in a GPIIb/IIIa dependent manner to enhance aggregate size. This was consistent with the findings that RMP-induced augmentation of platelet aggregation at relevant levels of ADP or AA concentrations in heparinized blood [Jy, et al; Thromb Haemost, in press]. We are continuing to investigate conditions affecting the interactions between RMP and platelets. Disclosures: No relevant conflicts of interest to declare.


Blood ◽  
1994 ◽  
Vol 84 (7) ◽  
pp. 2206-2213 ◽  
Author(s):  
A Diquelou ◽  
S Lemozy ◽  
D Dupouy ◽  
B Boneu ◽  
K Sakariassen ◽  
...  

Abstract We have investigated the influence of blood flow on thrombin generation, fibrin formation, and fibrin deposition on procoagulant and nonprocoagulant surfaces. Nonanticoagulated human blood was drawn for 5 minutes directly from an antecubital vein over stimulated endothelial cells expressing tissue factor and over human type III collagen fibrils, positioned in parallel-plate perfusion chambers. The shear rates at these surfaces were 50, 650, and 2,600 s-1. Deposition of platelets and fibrin was measured by morphometry. Thrombin and fibrin formation was determined by measuring prothrombin fragments 1 + 2 (F 1 + 2), thrombin-antithrombin III complexes, (T-AT) and fibrinopeptide A (FPA) in blood effluent from the perfusion chamber at the end of the 5- minute perfusion period. On procoagulant endothelial cells, the thrombi were primarily composed of fibrin. The fibrin deposition (81%, 21%, and 2% at 50, 650, and 2,600 s-1, respectively) and plasma levels of F 1 + 2, T-AT and FPA were shear rate dependent and highest at 50 s-1. There was a positive correlation between F 1 + 2 and T-AT and the fibrin deposition (P < .01). In contrast, the collagen surface triggered primarily thrombi that were composed of platelets. The platelet thrombi and plasma levels of F 1 + 2 and T-AT were also dependent on the shear rate, but highest at 650 and 2,600 s-1. F 1 + 2 and T-AT reached the same level as observed with procoagulant endothelial cells at the higher shear rates. There was a positive correlation between F 1 + 2 and T-AT and the platelet thrombus formation (P < .05), confirming the predominant role of platelets in thrombin generation. Thus, thrombin formation is strongly influenced by the blood flow, and this effect depends on the composition of the thrombogenic surface.


2012 ◽  
Vol 35 (6) ◽  
pp. 425-434 ◽  
Author(s):  
Won Kim ◽  
Sung Kwang Park ◽  
Kyung Pyo Kang ◽  
Dong Hwan Lee ◽  
Sam Yeon Kim ◽  
...  

Background: Elevated blood viscosity has been shown to be independently correlated with cardiovascular risk factors and associated with increased risk of major cardiovascular events, including death and acute myocardial infarction. The aim of the present study was to investigate changes in whole blood viscosity (WBV) at shear rates of 1, 5, and 300 s-1 before and after hemodialysis in patients with end-stage renal disease (ESRD). We also examined the relationship between the changes of WBV and intravascular blood volume. Methods: 43 patients with ESRD receiving maintenance hemodialysis were enrolled. WBV was measured using a scanning capillary tube viscometer pre- and post-dialysis to quantify dialytic viscosity surges. Body weight, blood pressure, and hematocrit were also measured before and after hemodialysis, as was the fluid removed during the session. Results: Hemodialysis had a 3 times greater impact on the low-shear WBV at a shear rate of 1 s-1 (i.e., 44.1% change) than on the high-shear WBV at a shear rate of 300 s-1 (i.e., 15.9% change). Changes in the low-shear WBV obtained at shear rates of 1 and 5 s-1 during hemodialysis were significantly correlated with changes in hematocrit. The intravascular blood volume reduction during hemodialysis was positively correlated with the changes in both high-shear and low-shear WBVs. Conclusions: These results suggest that the WBV parameter may hold additional information beyond hemoconcentration. Further research is needed to evaluate the relationship between low-shear WBV surges and increased morbidity in the patient population with ESRD.


2016 ◽  
Vol 138 (8) ◽  
Author(s):  
Gaku Tanaka ◽  
Ryuhei Yamaguchi ◽  
Hao Liu ◽  
Toshiyuki Hayase

For laminar flow in the side branch of a T-junction, periodic fluid vibrations occur with the Strouhal number independent of characteristic flow conditions. As the mechanics is unknown, an experiment was performed to establish the underlying cause in high-shear-rate flow. The fluid vibration appears along both the shearing separation layer and the boundary between two vortices immediately downstream of the side branch, where the shear rates are several orders larger than those further downstream. This vibration is caused by flow instability induced in two types of high-shear-rate flow confirming that is a universal phenomenon associated with the geometry of the T-junction.


1994 ◽  
Vol 71 (01) ◽  
pp. 103-109 ◽  
Author(s):  
Helge E Roald ◽  
R Marius Barstad ◽  
Anne Engen ◽  
Peter Kierulf ◽  
Fredrik Skjørten ◽  
...  

SummaryIn the present study we have investigated the effect of a 100 mg single oral dose of a newly developed thromboxane A2 receptor antagonist on collagen-induced thrombogenesis in flowing human non-anticoagulated blood. Blood was drawn directly from an antecubital vein over immobilised collagen type III fibrils on a cover slip placed in a parallel-plate perfusion chamber. Shear rates at the collagen surface were characteristic for medium sized (650 s−1) and moderately stenosed (2,600 s−1) arteries. Blood-collagen interactions were morphologically quantified as platelet-collagen adhesion, fibrin deposition and thrombus volume. Activation peptides of coagulation, fibrinopeptide A (FPA), and of platelets, β-thromboglobulin (β-TG), were measured immediately distal to the perfusion chamber.HN-11500 ingestion reduced significantly the thrombus volume by 32% at 2,600 s−1, but not at 650 s−1. However, transmission electron microscopy revealed loosely packed and less degranulated platelets at 650 s−1. The β-TG plasma levels were also reduced at both shear rates by the HN-11500 ingestion. The platelet-collagen adhesion was significantly enhanced at both shear rates. This was apparently a consequence of higher platelet concentrations at the collagen surface, because fewer platelets were consumed by the thrombi after the drug ingestion. In contrast, the coagulation, as measured by fibrin deposition and FPA plasma levels, was not significantly affected by HN-11500.Thus, it appears that the thromboxane A2 receptor antagonist HN-11500 reduces the thrombotic response by primarily impairing the platelet function at arterial blood flow conditions, and particularly at high wall shear rates.


Sign in / Sign up

Export Citation Format

Share Document